XEN Gel Stent for glaucoma treatment

NIHR HSRIC
Record ID 32016000444
English
Authors' objectives: The XEN Gel Stent is a glaucoma drainage implant developed by AqueSys, Inc, and distributed in the UK by Kestrel Ophthalmics Limited. Its aim is to reduce intraocular pressure (IOP) in patients with primary open angle glaucoma where previous medical treatments have failed.
Details
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Humans
  • Glaucoma
  • Stents
Contact
Organisation Name: NIHR Horizon Scanning Centre
Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name: c.packer@bham.ac.uk
Contact Email: c.packer@bham.ac.uk
Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.